tert-Butylhydroquinone Treatment Alleviates Contrast-Induced Nephropathy in Rats by Activating the Nrf2/Sirt3/SOD2 Signaling Pathway

Figure 2

t-BHQ alleviated histological change: (a) control group; (b) ioversol group; (c) t-BHQ+ioversol group; (d) t-BHQ group. Rats in the ioversol group were sequentially injected in the tail vein: indomethacin (10 mg/kg), followed by L-NAME (100 mg/kg) and ioversol (2.9 g/kg) 15 and 30 min later. t-BHQ was administered to rats in the t-BHQ+ioversol group.

(a)

(b)

(c)

(d)